BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22088624)

  • 1. Re: impact of patient age on outcome following bladder-preserving treatment for non-muscle-invasive bladder cancer.
    Griebling TL
    J Urol; 2011 Feb; 185(2):466-7. PubMed ID: 22088624
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of patient age on outcome following bladder-preserving treatment for non-muscle-invasive bladder cancer.
    Kohjimoto Y; Iba A; Shintani Y; Inagaki T; Uekado Y; Hara I
    World J Urol; 2010 Aug; 28(4):425-30. PubMed ID: 20130884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The survival of patients with bladder tumors treated by surgery: comparative results of an old and a recent series.
    McCarron JP; Marshall VF
    J Urol; 1979 Sep; 122(3):322-4. PubMed ID: 470002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgical treatment possibilities in bladder cancer].
    Staehler W
    Wien Med Wochenschr; 1971 Nov; 121(47):841-3. PubMed ID: 4943402
    [No Abstract]   [Full Text] [Related]  

  • 6. [New developments in the treatment of muscle-invasive bladder cancer].
    Kerst JM; Pos FJ; Visser O; Horenblas S
    Ned Tijdschr Geneeskd; 2008 Jan; 152(4):187-92. PubMed ID: 18320942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-muscle invasive bladder cancer with concomitant vaginal urothelial carcinoma: a case report and review of the literature.
    Kaneko G; Kikuchi E; Hasegawa M; Miyajima A; Nakagawa K; Kameyama K; Oya M
    Int J Clin Oncol; 2010 Dec; 15(6):626-30. PubMed ID: 20544250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The case for conservative management in the treatment of patients with non-muscle-invasive micropapillary bladder carcinoma without carcinoma in situ.
    Gaya JM; Palou J; Algaba F; Arce J; Rodríguez-Faba O; Villavicencio H
    Can J Urol; 2010 Oct; 17(5):5370-6. PubMed ID: 20974029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder conservation for muscle-invasive bladder cancer.
    Hoskin P; Dubash S
    Expert Rev Anticancer Ther; 2012 Aug; 12(8):1015-20. PubMed ID: 23030221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Ben J. Challacombe, Bernard H. Bochner, Prokar Dasgupta, et al. The role of laparoscopic and robotic cystectomy in the management of muscle-invasive bladder cancer with special emphasis on cancer control and complications. Eur Urol 2011;60:767-75.
    Simonato A; Ennas M
    Eur Urol; 2012 Apr; 61(4):e29; author reply e30. PubMed ID: 22206801
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of irradiation of bladder tumors by telecobalt (statistics of Pavilion V)].
    Bobillon J
    J Urol Nephrol (Paris); 1968 Jun; 74(6):469-76. PubMed ID: 5678501
    [No Abstract]   [Full Text] [Related]  

  • 12. Is repeat transurethral resection effective and necessary in patients with T1 bladder carcinoma?
    Yucel M; Hatipoglu NK; Atakanli C; Yalcinkaya S; Dedekarginoglu G; Saracoglu U; Aras E
    Urol Int; 2010; 85(3):276-80. PubMed ID: 20733272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of laparoscopic and robotic cystectomy in the management of muscle-invasive bladder cancer with special emphasis on cancer control and complications.
    Challacombe BJ; Bochner BH; Dasgupta P; Gill I; Guru K; Herr H; Mottrie A; Pruthi R; Redorta JP; Wiklund P
    Eur Urol; 2011 Oct; 60(4):767-75. PubMed ID: 21620562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial comment to characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy.
    Szarvas T
    Int J Urol; 2013 Sep; 20(9):872. PubMed ID: 23379970
    [No Abstract]   [Full Text] [Related]  

  • 15. Surgical management of bladder carcinoma.
    Carrion R; Seigne J
    Cancer Control; 2002; 9(4):284-92. PubMed ID: 12228754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The operative treatment of bladder carcinoma].
    Staehler W; Völter D
    Urologe A; 1973 Mar; 12(2):50-4. PubMed ID: 4698034
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cystectomy in bladder cancer patients].
    Galeev RKh
    Vopr Onkol; 1992; 38(9):1118-24. PubMed ID: 1300828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating octogenarians with muscle-invasive bladder cancer: preoperative opportunities for increasing the benefits of surgical intervention.
    Bassett JC; Chang SS
    Urol Oncol; 2014 Jan; 32(1):37.e13-6. PubMed ID: 23628313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A second transurethral resection could be not necessary in all high grade non-muscle-invasive bladder tumors].
    Gaya JM; Palou J; Cosentino M; Patiño D; Rodríguez-Faba O; Villavicencio H
    Actas Urol Esp; 2012 Oct; 36(9):539-44. PubMed ID: 22710093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endoscopic surveillance of superficial papillary tumors of the bladder].
    Desrez G; Mandron E; Chatelain C
    Cancer Radiother; 1998 Apr; 2 Suppl 1():27s-30s. PubMed ID: 9749074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.